|

Industry NEWS: The GOOD, The BAD, And The UGLY / New Psychedelic Studies, Legalization Bills & MORE!

ByPsychedelic Spotlight

Hey guys! In this week’s general industry news, we’ll cover some interesting developments. Some are probably going to make some of our viewers turn away from this week’s episode as they discover some pretty “depressing” statistics about North America’s current mental state. However, for those who stick around, you might end up finding that there might be a light at the end of the tunnel as you discover that psilocybin’s benefits might be extended to treat certain

Enjoy!
Links:
Psilocybin & Migraines: https://www.psypost.org/2021/05/a-single-dose-of-psilocybin-has-a-lasting-therapeutic-effect-on-migraine-headache-according-to-a-new-placebo-controlled-study-60793

Increased depression in North America:
https://www.meetfieldtrip.com/news/news-details/2021/Canadians-Are-Not-OK-83-of-Canadians-Report-One-Or-More-Symptoms-of-Depression-With-Many-Turning-To-Substances-To-Cope-With-Negative-Emotions-During-COVID-19-Pandemic-According-to-Field-Trip-Healths-First-Annual-State-of-Mind-Survey/default.aspx

https://www.meetfieldtrip.com/news/news-details/2021/More-than-80-of-Americans-report-one-or-more-symptoms-of-depression-and-many-have-turned-to-substances-to-cope-with-negative-emotions-during-COVID-19-Pandemic-according-to-Field-Trip-Healths-First-Annual-State-of-Mind-Survey/default.aspx

Opioid Overdose In Ontario:
https://www.cp24.com/news/opioid-overdose-deaths-up-75-per-cent-in-ontario-during-covid-19-pandemic-new-report-1.5434080

FDA Greenlights Ketamine:

FDA Green-Lights Ketamine Study for Side Effects of Parkinson’s Disease Treatment

California Bill to Decriminalize Psychedelics Passes Senate Floor:

California Bill To Legalize Possession Of Psychedelics Heads To Senate Floor After Committee Action

Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
Follow us on social media! 🙌

Instagram: @thepsychedelicinvestor
Email: thepsychedelicinvestor@gmail.com
Facebook: @thepsychedelicinvestor
Music: www.bensound.com
Video editing: @themyaholy
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor

DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

#MindMed #PsychedelicStocks #PsychedelicIndustry

Similar Posts

  • Why the SHROOM BOOM Isn’t Just About Psychedelic Mushrooms

    Learn, Videos

    How mushrooms are taking over the healthcare industry, and how investors can profit off of this. First we will talk about how they are being used as treatments for mental health conditions. And then we will talk about how regular, non psychedelic mushrooms are being used to promote healthy lifestyles, and perhaps even lengthen lifespans and increase quality of life.
    The psychedelic craze has overshadowed another important facet of mushrooms and the Shroom Boom.
    The health benefits and investing opportunities of non-psychedelic mushrooms.
    Fungi like Lion’s Mane, Chaga and reishi have a variety of health benefits, and have recently been labelled as superfoods.
    For example, Reishi mushrooms, which have been “revered in Asian societies for thousands of years”, have antibacterial, antiviral, and anti-fungal characteristics, and is high in proteins and vitamins.
    While this is great news for you health, and I personally incorporate mushroom extracts into my diet, on this channel we also focuses on investing.
    According to the Grand View Research Corporation, the global mushroom market, not including the psychedelic variety, is set to grow to an eye watering $50 billion annually by 2025.

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    The Psychedelic Investor was compensated $1,000 by Future Money Trends for the having the interview with PlantX CEO. James (The Psychedelic Investor) does not own a position in PlantX and will not open one for at least 30 days after publication of this video.

    Full Disclaimer
    https://www.goldstandardir.com/plantx-life-disclaimer-85/

    #ShroomBoom​​​ ​#PlantX​​​ #PsychedelicStocks

  • The Top 10 Psychedelics Stocks’ Financials COMPARED ( Atai, CMPS, MNMD, NUMI, RVV, DMT, TRIP+)

    Listen, Videos

    What’s up psychedelic investors! In this episode, we’ll be comparing the top 10 psychedelic stocks’ financials.
    Will look at the 4 most important financial stats for each of the top 10 companies in the Psychedelic Medicines field, selected by market cap.

    First, we will look at the market cap, because that tells us how valuable the market judges the company to be, and it tells us how easily a company can raise capital.
    Next, we will look at cash on hand.
    Third, we will look at how much a company is spending.
    Finally, we will look at revenue where applicable
    All figures are in American dollars.

    So which stocks we’ll be comparing, you may ask? We’ll look at:
    – Atai Life Sciences ( NASDAQ: ATAI)
    – Compass Pathways (NASDAQ: CMPS)
    -MindMed (NASDAQ: MNMD), ( NEO: MMED)
    – Cybin Inc (NYSE: CYBN)
    – Numinus Wellneass (TSX: NUMI) (OTC: LKYSF)
    – Revive Therapeutics (CN: RVV) (OTC: RVVTF)
    – Small Pharma ( TSX: DMT)
    -Mydecine (OTC: MYCOF) (NEO: MYCO)
    – Red Light Holland ( CSE: TRIP) (OTC: TRUFF)

    Enjoy the episode!

    Follow us on social media! 🙌
    Instagram: @thepsychedelicinvestor
    Facebook: @thepsychedelicinvestor

    Want to collaborate? Send us an email at:
    thepsychedelicinvestor@gmail.com

    Music from:
    www.bensound.com

    Video editing: @themyaholy

    Check out our Benziga discounts
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #ATAISTOCK #PsychedelicStocks

  • Is investing in PSYCHEDELIC STOCKS the future🍄? (Intro to The Psychedelic Investor)

    Listen, Videos

    So why do we think psychedelic stocks are the next big thing? Here is the story of how the Joe Rogan Podcast led one Tesla Investor to investing in psychedelic stocks and starting the channel: The Psychedelic Investor 🍄.

    From MindMed (MMED/MMEDF) to Compass Pathways (CMPS) and other growth stocks in the psychedelic landscape, we aim to cover the developments in the psychedelic stocks field. Our main goal is creating a community where information can be shared and we can learn each other. So is investing in psychedelic stocks the future? Guess we’ll find out soon enough: together.

    👍Like & Subscribe to join us on our journey to achieving Alpha Returns

    Music: www.bensound.com
    Instagram: @psychedelicinvestor
    Facebook: @thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    #PsychedelicStocks #MindMed #JoeRogan #Tesla #ShroomStocks #MMED #CMPS #ThePsychedelicInvestor